CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.
March 23rd 2022
Patients with PSMA-positive metastatic castration-resistant prostate cancer can now be treated with Pluvicto, which may provide hope to an unmet need in this patient population.
March 18th 2022
From two celebrity deaths due to cancer to leading American cancer organizations coming together to help patients with cancer fleeing Ukraine, here’s what’s happening in the cancer space this week.
March 16th 2022
In a news release, Merck advised patients enrolled on the trial to consult with their health care provider regarding their treatment.
March 15th 2022
Regardless of a man’s age, providing care to a partner or family member with cancer has been shown to take a drastic toll on their health. To make matters worse, research shows many men struggle in silence.
March 7th 2022
Patients treated with Lutetium-177 PSMA-617 tended to experience improvements in quality of life related to the aches and pains that can come from bone metastases.
February 21st 2022
Patients with nonmetastatic castration-resistant prostate cancer who were taking other medications or had health complications still derived a survival benefit from treatment with Nubeqa, research showed.
February 1st 2022
A phase 1/2a clinical trial examining the effects of a treatment called LAVA-1207 for patients with metastatic prostate cancer has now begun.
January 31st 2022
One expert noted that patients with prostate cancer can take a few months to make an informed treatment decision without impacting their long-term outcomes.
January 18th 2022
The STELLAR-002 trial is currently underway to examine the combination of XL092, an experimental tyrosine kinase inhibitor, in combination with immuno-oncology therapies for patients with advanced solid tumors.
January 17th 2022
Prostate cancer survivors are encouraged to include their partners in interventions to improve sexual function after treatment — and, as study results show, it is better to have these conversations with providers sooner rather than later.
January 11th 2022
Sexual dysfunction may often happen after prostate cancer treatment, and the results of one study shown that an online program for both the patient and their partner may help in this aspect of recovery.
December 23rd 2021
Additional advancements in how radical prostatectomy is performed are needed to improve other urinary outcomes such as good urinary function and social incontinence.
December 3rd 2021
The pharmaceutical company announced preliminary results on a phase 3 trial, which demonstrated that Nubeqa with docetaxel and androgen deprivation therapy may improve overall survival in men with metastatic hormone-sensitive prostate cancer.
December 2nd 2021
With recently revised treatment guidelines, doctors may be more likely to recommend active surveillance to men with low-risk prostate cancer.
November 15th 2021
Hypofractionated radiation for nearly five weeks in men with prostate cancer after surgery may have similar results without added side effects compared with radiation therapy for a standard duration of seven weeks.
November 15th 2021
A man reflects on slight symptoms he was not concerned about leading up to his prostate cancer diagnosis.
October 11th 2021
The first patient was enrolled in a phase 2 clinical trial for the treatment of hormone-sensitive advanced prostate cancer.
October 5th 2021
Treatments for bladder, colorectal and prostate cancer may cause sexual dysfunction in men. Here, an expert provides insight into how patients and survivors may improve their sexual health.
September 26th 2021
It is important that the whole community understand that basic research and clinical trials can continue to improve outcomes for patients with genitourinary cancer.
September 25th 2021
In this special issue of CURE®, we spoke with patients and health care providers about fertility issues, treatment advancements and other topics related to kidney, prostate, testicular and bladder cancers.
September 23rd 2021
The prescription of systemic cancer therapies varies based on a patient’s age, comorbidities, cancer stage and other variables, according to recent research.
September 17th 2021
Clinical trials that are designed to ask patients with bladder, kidney and prostate cancer about their smoking status may help patients better understand what to expect from their treatment based on their smoking habits.
September 16th 2021
The eligible age of 65 years for Medicare may be discouraging patients from getting screenings and tests as they wait for more health coverage.
September 15th 2021
Monitoring, rather than immediately treating, patients with low-risk prostate cancer may be a better approach, says an expert from UCSF Helen Diller Family Comprehensive Cancer Center.
September 13th 2021
After decades of research, scientists inch closer to FDA approval for PSMA-targeted treatments that show promise for patients with an advanced form of prostate cancer.
September 10th 2021
An ovarian cancer survivor shares what it was like to be her late husband’s caregiver when he had prostate cancer, years before her own diagnosis.
August 18th 2021
Widowers were more likely to be diagnosed with prostate cancer that had distant metastases, according to recent research.
August 13th 2021
From the state of the “Tiger King’s” Joe Exotic’s prostate cancer to the emotional reunion of two 3-year-old cancer survivors, here’s what’s happening in the cancer landscape this week.
August 2nd 2021
Our first imperative as cancer survivors is to travel on a journey of wellness and peace of mind, not fear and stress.